Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 347,000 | 171,000 | 548,000 | 429,000 | 283,000 |
| Depreciation Amortization | 89,000 | 43,000 | 154,000 | 114,000 | 76,000 |
| Income taxes - deferred | 106,000 | 54,000 | 186,000 | 141,000 | 95,000 |
| Accounts receivable | 32,000 | -57,000 | -70,000 | -100,000 | -125,000 |
| Accounts payable and accrued liabilities | 55,000 | 27,000 | N/A | 5,000 | -29,000 |
| Other Working Capital | -67,000 | -101,000 | -96,000 | -125,000 | -201,000 |
| Other Operating Activity | -211,000 | 0 | -6,000 | 10,000 | 97,000 |
| Operating Cash Flow | $351,000 | $137,000 | $716,000 | $474,000 | $196,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -82,000 | -44,000 | -137,000 | -105,000 | -70,000 |
| Purchase Of Investment | -843,000 | -361,000 | -1,657,000 | -1,061,000 | -578,000 |
| Sale Of Investment | 864,000 | 404,000 | 1,372,000 | 926,000 | 730,000 |
| Purchase Sale Intangibles | -106,000 | -104,000 | -92,000 | -77,000 | -76,000 |
| Other Investing Activity | -93,000 | -99,000 | -81,000 | -69,000 | -72,000 |
| Investing Cash Flow | $-154,000 | $-100,000 | $-503,000 | $-309,000 | $10,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -236,000 | N/A | N/A |
| Debt Issued | 46,000 | 46,000 | N/A | N/A | N/A |
| Debt Repayment | -46,000 | -46,000 | N/A | N/A | N/A |
| Common Stock Issued | 9,000 | 1,000 | 2,000 | 2,000 | 1,000 |
| Common Stock Repurchased | N/A | N/A | 3,000 | N/A | N/A |
| Dividend Paid | -80,000 | N/A | -61,000 | -60,000 | -61,000 |
| Other Financing Activity | -31,000 | -19,000 | -35,000 | -215,000 | -224,000 |
| Financing Cash Flow | $-102,000 | $-18,000 | $-327,000 | $-273,000 | $-284,000 |
| Exchange Rate Effect | -2,000 | -1,000 | 3,000 | 5,000 | 8,000 |
| Beginning Cash Position | 70,000 | 70,000 | 181,000 | 180,000 | 183,000 |
| End Cash Position | 163,000 | 88,000 | 70,000 | 76,000 | 112,000 |
| Net Cash Flow | $93,000 | $18,000 | $-111,000 | $-104,000 | $-71,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 351,000 | 137,000 | 716,000 | 474,000 | 196,000 |
| Capital Expenditure | -88,000 | -44,000 | -138,000 | -106,000 | -71,000 |
| Free Cash Flow | 263,000 | 93,000 | 578,000 | 368,000 | 125,000 |